DaVita Debt to Equity Ratio 2010-2024 | DVA

Current and historical debt to equity ratio values for DaVita (DVA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. DaVita debt/equity for the three months ending March 31, 2024 was 7.95.
DaVita Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-03-31 $16.30B $1.13B 14.39
2023-12-31 $15.65B $1.24B 12.58
2023-09-30 $15.55B $1.38B 11.27
2023-06-30 $15.75B $1.21B 13.06
2023-03-31 $15.71B $1.02B 15.40
2022-12-31 $16.05B $0.88B 18.33
2022-09-30 $16.26B $0.70B 23.16
2022-06-30 $16.33B $0.78B 21.06
2022-03-31 $16.07B $1.02B 15.78
2021-12-31 $16.19B $0.94B 17.29
2021-09-30 $16.31B $1.33B 12.28
2021-06-30 $16.35B $1.46B 11.18
2021-03-31 $16.21B $1.43B 11.31
2020-12-31 $15.42B $1.57B 9.84
2020-09-30 $15.29B $1.75B 8.72
2020-06-30 $16.97B $2.33B 7.27
2020-03-31 $15.46B $2.13B 7.25
2019-12-31 $14.99B $2.32B 6.46
2019-09-30 $14.94B $2.51B 5.95
2019-06-30 $15.69B $4.24B 3.70
2019-03-31 $18.52B $4.09B 4.53
2018-12-31 $15.20B $3.91B 3.89
2018-09-30 $15.33B $4.03B 3.80
2018-06-30 $14.95B $4.49B 3.33
2018-03-31 $14.16B $4.78B 2.96
2017-12-31 $14.09B $4.89B 2.88
2017-09-30 $14.04B $4.97B 2.83
2017-06-30 $14.07B $5.27B 2.67
2017-03-31 $14.05B $5.34B 2.63
2016-12-31 $13.91B $4.85B 2.87
2016-09-30 $13.81B $5.12B 2.70
2016-06-30 $13.73B $4.96B 2.77
2016-03-31 $13.59B $4.92B 2.76
2015-12-31 $13.43B $5.08B 2.64
2015-09-30 $13.70B $5.19B 2.64
2015-06-30 $13.60B $5.35B 2.54
2015-03-31 $13.20B $5.17B 2.55
2014-12-31 $12.26B $5.36B 2.29
2014-09-30 $12.95B $5.15B 2.51
2014-06-30 $12.97B $4.96B 2.62
2014-03-31 $12.56B $4.84B 2.60
2013-12-31 $12.49B $4.61B 2.71
2013-09-30 $12.39B $4.44B 2.79
2013-06-30 $12.17B $4.28B 2.84
2013-03-31 $12.46B $3.96B 3.15
2012-12-31 $12.10B $3.92B 3.09
2012-09-30 $8.15B $2.67B 3.05
2012-06-30 $6.75B $2.51B 2.69
2012-03-31 $6.76B $2.40B 2.81
2011-12-31 $6.64B $2.27B 2.93
2011-09-30 $6.62B $2.08B 3.18
2011-06-30 $6.25B $1.95B 3.21
2011-03-31 $6.19B $2.14B 2.90
2010-12-31 $6.08B $2.04B 2.98
2010-09-30 $5.25B $2.38B 2.21
2010-06-30 $5.22B $2.36B 2.22
2010-03-31 $5.37B $2.32B 2.32
2009-12-31 $5.36B $2.19B 2.45
2009-09-30 $5.40B $2.14B 2.53
2009-06-30 $5.39B $2.06B 2.62
2009-03-31 $5.31B $1.92B 2.76
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $11.923B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.827B 10.78
Quest Diagnostics (DGX) United States $16.063B 16.60
Encompass Health (EHC) United States $8.608B 22.03
Chemed (CHE) United States $8.132B 25.20
Elanco Animal Health (ELAN) United States $6.597B 17.11
Option Care Health (OPCH) United States $5.235B 19.82
RadNet (RDNT) United States $4.632B 96.45
Amedisys (AMED) United States $3.202B 22.68
Astrana Health (ASTH) United States $2.666B 36.05
Addus HomeCare (ADUS) United States $2.179B 28.20
LifeStance Health (LFST) United States $2.095B 0.00
U.S Physical Therapy (USPH) United States $1.424B 38.10
Pennant (PNTG) United States $0.789B 41.67
Aveanna Healthcare Holdings (AVAH) United States $0.677B 0.00
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
Novo Integrated Sciences (NVOS) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00